NT-proBNP-based strategy improves long-term heart failure outcomes and saves costs despite initial short-term investment in Brazilian private healthcare.
Does an NT-proBNP-based strategy improve health outcomes and provide cost savings in people with Type 2 diabetes?
An NT-proBNP-based strategy for evaluating and managing patients with type 2 diabetes is cost-effective in the Brazilian private healthcare system by reducing long-term heart failure burden.
Tasa de eventos absoluta: 0% vs 0%
NT-proBNP-based strategy offers improved health outcomes and cost savings by reducing the long-term HF burden. Although the short-term budget impact indicates an initial net investment, the full clinical benefit of cardioprotective treatment is observed in a longer time horizon.
Lemos et al. (Wed,) reported a other. NT-proBNP-based strategy improves long-term heart failure outcomes and saves costs despite initial short-term investment in Brazilian private healthcare.